We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.13B
AUM Growth
+$281M
Cap. Flow
+$61.6M
Cap. Flow %
1.97%
Top 10 Hldgs %
12.2%
Holding
1,543
New
228
Increased
546
Reduced
510
Closed
166

Top Buys

Rank Stock Value
1
TLOG
TetraLogic Pharmaceuticals Corporation
TLOG
+$8.36M
2
PRF icon
Invesco FTSE RAFI US 1000 ETF
PRF
+$8.14M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$5.91M
4
KMB icon
Kimberly-Clark
KMB
+$5.03M
5
EWU icon
iShares MSCI United Kingdom ETF
EWU
+$3.89M

Top Sells

Rank Stock Value
1
ELD icon
WisdomTree Emerging Markets Local Debt Fund
ELD
+$5.52M
2
BKLN icon
Invesco Senior Loan ETF
BKLN
+$5.39M
3
IXG icon
iShares Global Financials ETF
IXG
+$5.36M
4
CVE icon
Cenovus Energy
CVE
+$5.09M
5
EPP icon
iShares MSCI Pacific ex Japan ETF
EPP
+$4.89M

Sector Composition

Rank Sector Weight
1 Energy 12.37%
2 Healthcare 10.59%
3 Industrials 9.5%
4 Financials 9.49%
5 Technology 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LH icon
1426
Labcorp
LH
$25.9B
– –
-2,407
Closed -$205K
MBOT icon
1427
Microbot Medical
MBOT
$127M
– –
-10
Closed -$26K
MKTX icon
1428
MarketAxess Holdings
MKTX
$5.72B
– –
-5,503
Closed -$330K
MYRG icon
1429
MYR Group
MYRG
$5.25B
– –
-36,200
Closed -$880K
SDEV
1430
Stablecoin Development Corp
SDEV
$52M
– –
0
– -$26K
NRG icon
1431
NRG Energy
NRG
$24.8B
– –
-13,184
Closed -$360K
NRK icon
1432
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$912M
– –
-18,876
Closed -$231K
OLN icon
1433
Olin
OLN
$2.12B
– –
-11,237
Closed -$259K
OMCL icon
1434
Omnicell
OMCL
$1.68B
– –
-16,001
Closed -$379K
OSIS icon
1435
OSI Systems
OSIS
$3.89B
– –
-3,285
Closed -$244K
PCN
1436
PIMCO Corporate & Income Strategy Fund
PCN
$885M
– –
-10,110
Closed -$169K
PDT
1437
John Hancock Premium Dividend Fund
PDT
$626M
– –
-17,315
Closed -$207K
PENN icon
1438
PENN Entertainment
PENN
$2.71B
– –
-16,250
Closed -$203K
PHI icon
1439
PLDT
PHI
$4.33B
– –
-3,000
Closed -$204K
PRFZ icon
1440
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.88B
– –
-225,170
Closed -$4.03M
PRGO icon
1441
Perrigo
PRGO
$1.78B
– –
-25,555
Closed -$3.15M
PRLB icon
1442
Protolabs
PRLB
$2.13B
– –
-4,173
Closed -$319K
RBBN icon
1443
Ribbon Communications
RBBN
$383M
– –
-3,918
Closed -$66K
RFG icon
1444
Invesco S&P MidCap 400 Pure Growth ETF
RFG
$358M
– –
-9,790
Closed -$218K
RIGL icon
1445
Rigel Pharmaceuticals
RIGL
$750M
– –
-2,000
Closed -$72K
RYN icon
1446
Rayonier
RYN
$6.55B
– –
-11,807
Closed -$445K
SLRC icon
1447
SLR Investment Corp
SLRC
$715M
– –
-16,360
Closed -$363K
STM icon
1448
STMicroelectronics
STM
$50B
– –
-16,018
Closed -$147K
TCRT icon
1449
Alaunos Therapeutics
TCRT
$4.86M
– –
-67
Closed -$39K
TFX icon
1450
Teleflex
TFX
$5.98B
– –
-2,903
Closed -$239K
56 57
58
59 60

Similar funds

AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Oppenheimer & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Oppenheimer & Co held 1,543 positions worth $3.13B, up 9.9% from $2.84B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co's Q4 2013 filing shows 228 new, 546 increased, 510 reduced and 166 closed positions. Its largest new stake was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M. The largest sale was WisdomTree Emerging Markets Local Debt Fund, an estimated $5.52M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Industrials.

  • Oppenheimer & Co's largest Q4 2013 buy was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M.
  • Oppenheimer & Co added most to Invesco FTSE RAFI US 1000 ETF in Q4 2013, an estimated $8.14M increase.
  • Oppenheimer & Co's biggest Q4 2013 reduction was WisdomTree Emerging Markets Local Debt Fund, cutting an estimated $5.52M.
  • Oppenheimer & Co fully exited iShares Global Financials ETF in Q4 2013, selling an estimated $5.36M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.13B portfolio in Q4 2013.
  • Oppenheimer & Co opened 228 new positions and closed 166 in Q4 2013.
  • Oppenheimer & Co's portfolio value rose 9.9% quarter-over-quarter to $3.13B.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.